135 related articles for article (PubMed ID: 21222553)
1. DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours.
Lewis AL; Holden RR
Expert Opin Drug Deliv; 2011 Feb; 8(2):153-69. PubMed ID: 21222553
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.
Malagari K
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1643-50. PubMed ID: 18925855
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
[TBL] [Abstract][Full Text] [Related]
5. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
[TBL] [Abstract][Full Text] [Related]
6. A new tool to enhance the efficacy of chemoembolization to treat primary and metastatic hepatic tumors.
Fiorentini G
Expert Opin Drug Deliv; 2011 Apr; 8(4):409-13. PubMed ID: 21413909
[TBL] [Abstract][Full Text] [Related]
7. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery embolization systems: a physician's perspective.
Nicolini A; Crespi S; Martinetti L
Expert Opin Drug Deliv; 2011 Aug; 8(8):1071-84. PubMed ID: 21692688
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin -eluting beads in the treatment of liver carcinoma.
Vogl TJ; Lee C
Expert Opin Pharmacother; 2014 Jan; 15(1):115-20. PubMed ID: 24215628
[TBL] [Abstract][Full Text] [Related]
10. Intra-arterial EmboCept S® and DC Bead® effectively inhibit tumor growth of colorectal rat liver metastases.
Ziemann C; Roller J; Malter MM; Keller K; Kollmar O; Glanemann M; Menger MD; Sperling J
BMC Cancer; 2019 Oct; 19(1):938. PubMed ID: 31601175
[TBL] [Abstract][Full Text] [Related]
11. DC Bead: a major development in the toolbox for the interventional oncologist.
Lewis AL
Expert Rev Med Devices; 2009 Jul; 6(4):389-400. PubMed ID: 19572794
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
13. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.
Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL
J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626
[TBL] [Abstract][Full Text] [Related]
14. An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin.
de Baere T; Plotkin S; Yu R; Sutter A; Wu Y; Cruise GM
J Vasc Interv Radiol; 2016 Sep; 27(9):1425-1431. PubMed ID: 27402527
[TBL] [Abstract][Full Text] [Related]
15. Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead
Lewis AL; Hall B
Future Oncol; 2019 Jun; 15(17):2053-2068. PubMed ID: 30942614
[TBL] [Abstract][Full Text] [Related]
16. Advances in regional chemotherapy of the liver.
Dudeck O; Ricke J
Expert Opin Drug Deliv; 2011 Aug; 8(8):1057-69. PubMed ID: 21506902
[TBL] [Abstract][Full Text] [Related]
17. DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.
Lewis AL; Dreher MR; O'Byrne V; Grey D; Caine M; Dunn A; Tang Y; Hall B; Fowers KD; Johnson CG; Sharma KV; Wood BJ
J Mater Sci Mater Med; 2016 Jan; 27(1):13. PubMed ID: 26676859
[TBL] [Abstract][Full Text] [Related]
18. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.
Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF
Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866
[TBL] [Abstract][Full Text] [Related]
19. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
Engel J; Emons G; Pinski J; Schally AV
Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
[TBL] [Abstract][Full Text] [Related]
20. Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin.
Martin RC; Robbins K; Fagés JF; Romero FD; Rustein L; Tomalty D; Monaco R
Breast Cancer Res Treat; 2012 Apr; 132(2):753-63. PubMed ID: 22200868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
